(Q51606924)

8 April 2018

title

A pilot randomized trial of nebulized amphotericin in patients with allergic bronchopulmonary aspergillosis. (English)

1 reference

8 April 2018

allergic bronchopulmonary aspergillosis

main subject

0 references

author

Ritesh Agarwal

8

1 reference

8 April 2018

Sahajal Dhooria

3

Sahajal Dhooria

1 reference

8 April 2018

Arunaloke Chakrabarti

7

Arunaloke Chakrabarti

1 reference

8 April 2018

Inderpaul Singh Sehgal

4

Inderpaul Singh Sehgal

1 reference

8 April 2018

Digambar Behera

6

Digambar Behera

1 reference

8 April 2018

Ashutosh Nath Aggarwal

2

Ashutosh N Aggarwal

1 reference

8 April 2018

Mandeep Garg

5

Mandeep Garg

1 reference

8 April 2018

author name string

Babu Ram

1

1 reference

8 April 2018

language of work or name

English

0 references

publication date

15 December 2015

1 reference

8 April 2018

published in

Journal of Asthma

1 reference

8 April 2018

volume

53

1 reference

8 April 2018

issue

5

1 reference

8 April 2018

page(s)

517-524

1 reference

8 April 2018

Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria

cites work

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

The clinical spectrum of pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Allergic bronchopulmonary aspergillosis and Aspergillus infection in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Diagnosis of allergic bronchopulmonary aspergillosis: a case-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Estimation of the burden of chronic and allergic pulmonary aspergillosis in India

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Broncho-pulmonary aspergillosis; a review and a report of eight new cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Allergic bronchopulmonary aspergillosis in asthma: epidemiological, clinical and therapeutic issues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

A review on the clinical use of inhaled amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Aerosolized amphotericin B as prophylaxis for invasive pulmonary aspergillosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Role of inhaled amphotericin in allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Nebulised liposomal amphotericin B for Aspergillus lung diseases: case series and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Pictorial essay: Allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an analysis of 155 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Clinical significance of decline in serum IgE levels in allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with acute severe asthma in a respiratory intensive care unit in North India.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Allergic bronchopulmonary aspergillosis with aspergilloma: an immunologically severe disease with poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Serologic allergic bronchopulmonary aspergillosis (ABPA-S): long-term outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Chest radiographic and computed tomographic manifestations in allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: a latent class analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Cut-off values of serum IgE (total and A. fumigatus -specific) and eosinophil count in differentiating allergic bronchopulmonary aspergillosis from asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

A questionnaire-based study on the role of environmental factors in allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Use of nebulized amphotericin B in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

When oral corticosteroids are essential for persistent severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Amphotericin B disposition after aerosol inhalation in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Aerosol amphotericin B for prevention of invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Use of amphotericin B aerosols for the prevention of pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Allergic bronchopulmonary aspergillosis in a lung transplant patient successfully treated with nebulized amphotericin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Allergic bronchopulmonary aspergillosis in a 9-year-old boy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Adherence to montelukast versus inhaled corticosteroids in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Nebulised corticosteroid and amphotericin B: an alternative treatment for ABPA?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Aerosolized amphotericin for the treatment of allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Role of nebulized amphotericin B in the management of allergic bronchopulmonary aspergillosis in cystic fibrosis: Case report and review of literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Efficacy of aerosolized amphotericin B desoxycholate and liposomal amphotericin B in the treatment of invasive pulmonary aspergillosis in severely immunocompromised rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Allergic Bronchopulmonary Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Pulse methylprednisolone in allergic bronchopulmonary aspergillosis exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Clinical significance of Aspergillus sensitisation in bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Utility of IgE (total andAspergillus fumigatusspecific) in monitoring for response and exacerbations in allergic bronchopulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

What is the current place of azoles in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

Efficacy of nebulised liposomal amphotericin B in the attack and maintenance treatment of ABPA: Figure 1–

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2015.1127935

10.3109/02770903.2015.1127935

21 January 2018

Identifiers

DOI

1 reference

8 April 2018

1 reference

8 April 2018